Important security note: Warning of attempted fraud in the name of DWS
We have detected that fraudulent individuals are misusing the "DWS" trademark and the names of DWS employees on the internet and social media. These fraudsters are operating fake websites, Facebook pages, WhatsApp groups and Mobile Apps. Please be aware that DWS does not have any Facebook Ambassador profiles or WhatsApp chats. If you receive any unexpected calls, messages, or emails claiming to be from DWS, exercise caution and do not make any payments or disclose personal information. We encourage you to report any suspicious activity to info@dws.com, including any relevant documents and the original fraudulent email. Additionally, if you believe you have been a victim of fraud, please notify your local authorities and take steps to protect yourself.
13/08/2026
Recent weeks have been marked by sharp price swings in technology, particularly in chip stocks. The South Korean equity market, dominated by semiconductor stocks, has roughly halved within five weeks and is nevertheless still up by about 50 percent year to date.
Recent weeks have been marked by sharp price swings in technology, particularly in chip stocks. The South Korean equity market, dominated by semiconductor stocks, has roughly halved within five weeks and is nevertheless still up by about 50 percent year to date. US technology heavyweights also posted intraday swings in the double digits. “Markets will probably need a little more time to decide whether the correction in some technology stocks has led to a sufficient clean-out,” says Chief Investment Officer Vincenzo Vedda. “We are using the pullbacks in semiconductors to upgrade the segment again.
” Earnings momentum at memory-chip makers is likely to be cyclical, and current net margins of 60 percent are unlikely to be sustainable over several years. The supply of memory chips, however, is likely to grow only slowly and should face demand that is expected to continue increasing for at least several quarters. “Price falls of in some cases 60 percent, fuelled in part by leveraged forced selling, are in our view signs of an overreaction,” Vedda says. Warning signs are nevertheless present.
The risk that investment in data centres may have peaked by 2028 at the latest cannot be dismissed. Rising bond yields and rapidly widening costs for insuring against borrower default among neocloud providers, which offer powerful, cost-efficient AI infrastructure, are a warning signal. Vedda also sees partial overreactions in the global software and services sector, which has come under heavy pressure. Valuations have now fallen markedly; in September 2025, the price/earnings ratio was still 28, compared with 18 today. “We see selective opportunities emerging again here and have therefore upgraded the sector to ‘neutral’,” Vedda says.
Economy: Slight improvement in Germany
Inflation: Price increases in the eurozone and Germany clearly above the 2.0 percent target
Central banks: Uncertainty about US interest-rate policy has increased
Risks: War in the Middle East and implications for oil prices and inflation
Is the healthcare sector an alternative to technology stocks? In recent years, that would not have been a good idea. It used to be different. “The divergence between the earning and valuations of the two sectors has essentially emerged only over the past two to three years and was driven primarily by the euphoria around artificial intelligence (AI),” says investment strategist Dirk Schlüter, who uses the proprietary CROCI approach to value equities, making the intrinsic value of stocks more comparable. CROCI stands for Cash Return On Capital Invested, meaning return on capital employed. How rapid the divergent development over the past ten years has been is evident from market capitalisation.
Ten years ago, the market capitalisation of the US technology sector was still comparable with that of the healthcare sector. Today, it is more than three times as high. Particularly striking is the market’s pessimistic assessment of pharmaceutical companies, which play a crucial role in healthcare. Companies for which more than half of their 2024 revenues are affected by patents expiring by 2030 performed especially poorly. “The market is currently pricing in that around 40 percent of these companies’ economic earnings will disappear permanently. It is effectively assuming the worst case, namely that these companies will find no replacement in their product pipeline, either organically or through acquisitions,” Schlüter says.
A similar situation also occurred in the early 2000s. Back then, pharmaceutical companies ultimately proved to be a major investment opportunity. Earnings declined in the short term somewhat. Ultimately, however, the companies found replacements in their product pipelines. “Today, even companies without an aggravated patent issue are valued very low by the market,” Schlüter says. The pessimistic market assessment is particularly questionable because it seems plausible that in the next phase of the AI revolution, when profits are primarily captured by users of AI, the pharmaceutical sector could be among the winners. “There are already early reports of medical research successes that, thanks to the use of AI, could lead to faster and more successful drug development,” Schlüter says.
Comparison of economic profits in the IT and healthcare sectors
Source: DWS, CROCI, as of 01 July 2026
|
|
Strong earnings growth supports equity markets
|
Further upside despite an impressive rally
|
Market volatility has increased in recent weeks, not least in chip and technology stocks. Is this more of an entry opportunity, or a wake-up call to reduce equity exposure and allocate more to bonds and other asset classes? “In principle, we currently have a neutral stance on equities as an asset class,” says Vera Fehling, Chief Investment Strategist Western Europe. “We currently count emerging markets and Japan among the most promising regions.” The capital-market strategist sees the increased volatility in emerging markets more as an entry opportunity than as a cause for concern. Valuations are now more attractive, while the earnings-growth trend remains intact.
Bonds becoming more competitive
“We are also neutrally positioned in bonds at present, albeit with a slightly positive underlying tone. In general, we believe bonds should become significantly more competitive with equities again over the longer term,” says Fehling. Here, too, the picture is differentiated. The enormous issuance activity by large US hyperscalers such as Alphabet, Amazon, Meta and Microsoft continues to attract attention. However, the US has now also become the largest issuing country in this segment.
“So far, we view the rising US share of high-quality euro corporate bonds primarily as a welcome diversification opportunity, but we will monitor this closely into the autumn,” says Fehling. “We are currently cautious, meaning underweight, on riskier high-yield bonds with lower credit quality. In our view, spreads over government bonds are currently too low,” says Fehling. They do not adequately reflect the existing risks.
Importance of currency markets
Currency markets also deserve heightened attention. Recent interventions in favour of the Japanese yen suggest that an excessively weak yen is increasingly being perceived as a global risk. “Given the many market-moving issues, we believe a balanced portfolio that captures opportunities without losing sight of risks is particularly important,” Fehling concludes.
Attractive yield levels
|
Slightly lower yields expected
|
Risky, but with high yields
|
Investment Grade
USA | Eurozone |
USA | Eurozone |
|
|
LegendThe strategic view by July 2027 The indicators signal whether DWS expects the asset class in question to develop upwards, sideways or downwards. They indicate both the short-term and the long-term expected earnings potential for investors. Source: DWS Investment GmbH; CIO Office, as of 7 August 2026 | |
![]() |
|
![]() |
|
![]() |
|
Forecasts are based on assumptions, estimates, views and hypothetical models or analyses which may prove to be incorrect. Past performance is not indicative of future results.